Tobii informs the market of supply chain disruptions

Tobii AB (publ) today announces that one of its divisions, Tobii Dynavox, is expecting a delay in deliveries of some of its products. This is driven by supply chain disruptions caused by the current pandemic, coupled with high demand for the new I-Series product. The delay is estimated to result in a deferral of revenue of SEK 40-80m primarily from the second to the third quarter of 2021. The impact on full-year group earnings is expected to be immaterial.

The global disruptions in supply of primarily LCD panels caused by the pandemic, coupled with high demand for the I-Series product range is expected to create a temporary shortage of supply for Tobii Dynavox. Although customer delivery times are expected to be longer, the impact on order intake is likely to be limited.

Tobii Dynavox is working closely with its suppliers, customers, and partners to mitigate the situation. Customers affected by this will to the largest extent possible be offered alternative products from Tobii Dynavox while waiting for their I-Series shipment.

Based on currently available information, the delay is estimated to result in a deferral of revenue in the range of SEK 40-80m, from primarily the second to the third quarter 2021.

This information is information that Tobii AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, on March 11, 2021, at 8:00 p.m. CET.

Contact

Henrik Mawby, Head of Investor Relations, Tobii Group, phone: +46 (0)72 219 82 15, email: henrik.mawby@tobii.com

About Tobii

Tobii is the global leader in eye tracking. Our mission is to improve the world with technology that understands human attention and intent. Tobii operates through three business units: Tobii Dynavox makes specially designed computers that are controlled by eye movement or touch screens for use by people with special needs due to spinal cord injuries, CP, ALS or other medical conditions. Tobii Pro develops and sells eye tracking equipment and services used today by more than 3,500 companies and 2,500 research institutions, including 98 of the world’s 100 highest ranked universities. Tobii Tech supplies eye tracking technology for integration into consumer electronics and other products such as personal computers, virtual reality headsets, healthcare applications, and more. Tobii is headquartered in Sweden and is listed on Nasdaq Stockholm (TOBII). The group has over 1,000 employees. For more information: www.tobii.com.